Arthur F. Golden
Director · Turn Therapeutics Inc.
- 2025
- Jun 8, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur F. Golden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Abraham Chesed - $66K in TTRX purchases and sales in the last 12 months
- Zuraiz Chaudhary - $50K in TTRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arthur F. Golden?
Arthur F. Golden is a corporate insider, tracked as Director of Turn Therapeutics Inc. (TTRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Arthur F. Golden last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 6 filings going back to 2025.
Has Arthur F. Golden been buying or selling stock?
Recorded transactions: 3 open-market purchases ($193K) and 0 open-market sales across all tracked filings.
